Chromosomal breakage syndromes are a group of rare, inherited disorders characterized by defects in DNA repair that lead to increased cancer risk. The major types discussed were ataxia telangiectasia, Fanconi anemia, Bloom syndrome, and xeroderma pigmentosum. These syndromes are caused by mutations that disrupt critical DNA repair pathways, leading to genomic instability and improper DNA repair. Common features include cancer predisposition, developmental defects, and skin abnormalities like pigmentation changes. Diagnosis involves genetic testing, cytogenetic analysis of chromosome breaks and rearrangements, and assessing clinical manifestations.
This presentation is about Genomic imprinting. Genomic imprinting is only found in eutherians. In next few slides we'll try to understand this phenomena.
An oncogene is a gene that has the potential to cause cancer. In tumor cells, they are mutated or expressed at high levels. Most normal cells undergo a programmed form of rapid cell death (apoptosis) when critical functions are altered.
This presentation on Epigenetics is most advanced and evidence based one. Its Very helpful for Genetics students and research fellows, Reproductive Medicine specialist, Reproductive Biologist, Infertility practitioners
N-terminal tails of histones are the most accessible regions for modifications. These post-translational modification (PTM) of histones is a crucial step in epigenetic regulation of a gene.
there are s many methods are used in diagnosis of human gene mutation which occur disorders ,here u get information about the diagnostic method for genetic mutation detection
SNP (Single Nucleotide Polymorphic), SNP mapping, SNP profile, SNP types, SNP analysis by gel electropherosis and by mass spectrometry, SNP effects, single strand conformation polymorphism, SNP advantages and disadvantages and application of SNP profile in drug choice
Seminar led by Prof. Thomas Kaufmann. Institute of Pharmacology, University of Bern, Switzerland, at VHIR (15 November 2012).
Content: We are interested to investigate the molecular mechanisms by which pro- and anti-apoptotic members of the BCL-2 family regulate the intrinsic (mitochondrial) apoptotic pathway. The pathway is initiated by members of the BH3-only protein subgroup, which act as sensors in response to a variety of intracellular stress stimuli. Some BH3-only proteins, including Bid and Bim, can be activated downstream of death receptors (e.g. Fas/CD95, TNF-R1) and thus mediate a crosstalk from the extrinsic to the mitochondrial apoptotic pathway. We investigate these processes in mouse liver (and more recently also in mouse granulocytes), as hepatocytes strongly rely on this crosstalk for death receptor-induced apoptosis to be effective. We are further interested in the role of 'X-linked inhibitor of apoptosis protein' (XIAP) in these same cell death pathways.
A genetic disease is any disease caused by an abnormality in the genetic makeup of an individual. The genetic abnormality can range from minuscule to major - from a discrete mutation in a single base in the DNA of a single gene to a gross chromosomal abnormality involving the addition or subtraction of an entire chromosome or set of chromosomes. Some people inherit genetic disorders from the parents, while acquired changes or mutations in a preexisting gene or group of genes cause other genetic diseases. Genetic mutations can occur either randomly or due to some environmental exposure.
This presentation is about Genomic imprinting. Genomic imprinting is only found in eutherians. In next few slides we'll try to understand this phenomena.
An oncogene is a gene that has the potential to cause cancer. In tumor cells, they are mutated or expressed at high levels. Most normal cells undergo a programmed form of rapid cell death (apoptosis) when critical functions are altered.
This presentation on Epigenetics is most advanced and evidence based one. Its Very helpful for Genetics students and research fellows, Reproductive Medicine specialist, Reproductive Biologist, Infertility practitioners
N-terminal tails of histones are the most accessible regions for modifications. These post-translational modification (PTM) of histones is a crucial step in epigenetic regulation of a gene.
there are s many methods are used in diagnosis of human gene mutation which occur disorders ,here u get information about the diagnostic method for genetic mutation detection
SNP (Single Nucleotide Polymorphic), SNP mapping, SNP profile, SNP types, SNP analysis by gel electropherosis and by mass spectrometry, SNP effects, single strand conformation polymorphism, SNP advantages and disadvantages and application of SNP profile in drug choice
Seminar led by Prof. Thomas Kaufmann. Institute of Pharmacology, University of Bern, Switzerland, at VHIR (15 November 2012).
Content: We are interested to investigate the molecular mechanisms by which pro- and anti-apoptotic members of the BCL-2 family regulate the intrinsic (mitochondrial) apoptotic pathway. The pathway is initiated by members of the BH3-only protein subgroup, which act as sensors in response to a variety of intracellular stress stimuli. Some BH3-only proteins, including Bid and Bim, can be activated downstream of death receptors (e.g. Fas/CD95, TNF-R1) and thus mediate a crosstalk from the extrinsic to the mitochondrial apoptotic pathway. We investigate these processes in mouse liver (and more recently also in mouse granulocytes), as hepatocytes strongly rely on this crosstalk for death receptor-induced apoptosis to be effective. We are further interested in the role of 'X-linked inhibitor of apoptosis protein' (XIAP) in these same cell death pathways.
A genetic disease is any disease caused by an abnormality in the genetic makeup of an individual. The genetic abnormality can range from minuscule to major - from a discrete mutation in a single base in the DNA of a single gene to a gross chromosomal abnormality involving the addition or subtraction of an entire chromosome or set of chromosomes. Some people inherit genetic disorders from the parents, while acquired changes or mutations in a preexisting gene or group of genes cause other genetic diseases. Genetic mutations can occur either randomly or due to some environmental exposure.
Gene therapy of genetic disorders like hepatitis, neuroblastoma, thalassemiaD.R. Chandravanshi
Gene therapy is the modern techniques of treatment of various diseases and disorders.
Gene therapy is the introduction of genes into existing cells to prevent or cure a wide range of diseases.
It is a technique for correcting defective genes responsible for disease development.
Inactivating, or “knocking out,” a mutated gene that is functioning improperly.
The first approved gene therapy experiment occurred on September1990 in US, when Ashanti DeSilva was treated for ADA-SCID.
Under the direction of William French Anderson, at the National Institutes of Health (NIH),
DBA is a fascinating and complex erythroid disorder, as illustrated from the
study of the DBA family we described. Progress is being made in our understanding of the
molecular basis for DBA, pathophysiology of the disease, and developing and pursuing new
therapeutic options. In this review we studied that these advances will enable better clinical
management of the patients with DBA in the coming years. DBA diagnosis requires a correlation between examination findings and laboratory abnormalities demonstrating macrocytic anemia, elevated hemoglobin F levels, high erythrocyte deaminase activity, and confirmation with bone marrow biopsy and gene karyotyping.
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
5. INTRODUCTION
These are a group of disorders that are
characterized by a defect in DNA repair
mechanism or genomic instability.
Patients with these disorders show increased
predisposition to cancer.
Transmitted in autosomal recessive mode of
inheritence .
Rare syndromes.
6. CBS are associated with increase risk of
Leukemias,lymphomas,
solid tumors (eg, breast cancer, skin cancer).
immunodeficiencies,
growth retardation,
skeletal abnormalities,
Hypogonadism and
abnormal pigmentation.
7. PATHOGENESIS
Loss of DNA repair.
Inter strand cross links.
Genomic instability.
Increase exchange between sister chromatids.
Change in nucleotide.
Double strand DNA breaks.
8. Major types of syndromes
Ataxia telangiectasia (Louis bar syndrome)
Fanconi anemia.
Bloom syndrome.
Xeroderma pigmentosum.
10. ATAXIA TELANGIECTASIA
This syndrome was first described in 1941
by French physician Denise Louis-Bar.
It is caused because of chromosomal
instability.
It is a neuron degenerative disease mainly
affecting cerebellum.
Patients are particularly sensitive to
ionizing radiation and radiomimetic
compounds.
11. How is it caused?
It is caused due to
genetic mutation in
ATM gene on
chromosome 11
Ataxia Telangiectasia
Mutated gene
produces a mutated
ATM protein.
12. ATM gene
This protein is found in the cell nucleus.
Acting with other proteins, their role is to activate the
cells to repair damaged DNA.
Mutations in the ATM gene lead to total loss of the
ATM protein which normally recognizes DNA
damage.
13.
14. CLINICAL FEATURES
AGE: ataxia:1-4 years
At the age of 10 children are usually confined to a
wheelchair
Telangiectasias:2-8 Years
Frequency:1 case per 40,000-100,000 live births
Sex: Males and females affected equally
19. DIAGNOSIS
Immunoblotting for the protein for ATM is the preferred test for
diagnosis of ataxia telangiectasia.
Chorionic villi sample: Detect prenatal ataxia telangiectasia
Molecular genetic testing (DNA analysis) is performed to
identify the ATM mutation, if the mutation is detected, the
diagnosis of ataxia telangiectasia is confirmed.
Serum alpha-fetoprotein levels are elevated above 10 ng/mL in
more than 95% of patients with ataxia telangiectasia.
20. Serum immunoglobulin levels of IgA, IgG 2 or total IgG and
IgE are decreased markedly or even absent.
Brain MRI can detect cerebellar atrophy;
Brain single-photon emission computed tomography
(SPECT): indicates cerebellar regional cerebral blood flow
hypoperfusion
Cytogenetic analysis for chromosome breakage in dividing cells
exposed to irradiation.
Karyotyping is performed on peripheral blood.
Persons with ataxia telangiectasia frequently have
abnormalities involving chromosome 14, particularly a 7;14
chromosome translocation
21. MEDICAL CARE
Antioxidants
Immunisation
Systemic steroids
Intravenous immunoglobulin (IVIG) replacement
therapy.
Early and continuous physical therapy
Supportive therapy may lessen drooling,
choreoathetosis, and ataxia.
23. Fanconi anemia
Fanconi anemia is one of the inherited anemias that
causes bone marrow failure.
It is autosomal recessive disorder.
There are twelve complementation groups that have
been identified (A B C D1 D2 E F G I L and M) --
FA-A is the most common--
24. FA gene
It is located on chromosome 16.
It is a protein coding gene.
25. Functions of FA genes
DNA repair
Cell cycle control
Oxygen sensitivity
Apoptosis and telomere maintenance
Haemopoiesis
26. FA pathway
Proteins produced from these genes are involved in
a cell process known as the FA pathway.
The FA pathway is activated during the process of
DNA replication
The replication is blocked due to DNA damage.
The FA pathway sends certain proteins to the area
of damage, which trigger DNA repair.
27. Continued...
The FA pathway is particularly responsive to a
certain type of DNA damage known as interstrand
cross-links (ICLs).
FA proteins produce FA core complex .
The FA core complex activates two proteins, called
FANCD2 and FANCI
these two proteins brings DNA repair proteins to
the area of the ICL.
29. Mutations in FA gene
Mutations in FA gene
Disrupt FA pathway.
DNA damage is not repaired.
Abnormal cell death or uncontrolled cell growth
CANCER
30. Clinical Manifestations
AGE: 5-10 years
Frequency:1 case per1,00,000 live births
Sex: Males and females affected equally
31. Clinical Manifestations
Fanconi Anemia is characterized by physical
abnormalities
Abnormalities of the thumbs, forearms, skeletal
system, eyes, kidneys and urinary tract, ear, heart,
gastrointestinal system, oral cavity and central
nervous system.
Skin discolorations (hypo pigmented spots and
hyperpgimented spots)
32. Pancytopenia, bone marrow hypoplasia
developmental delay,
increased susceptibility to leukemia and other
malignancies,
Human papilloma virus (HPV) induced squamous
cell Carcinoma
Solid tumors - medulloblastoma, Wilm’stumor,
and breast cancer
38. TREATMENT
Bone marrow transplantation of
hematopoietic stem cells (HSC) can be
curative for hematologic symptoms.
Chemotherapy and radiation
Gene therapy
40. Bloom syndrome
It is an autosomal recessive disorder.
causes sun-sensitive skin changes, an increased risk of
cancer, and other health problems.
It caused by mutation in BLM gene.
Life span- 24 yrs.
41. BLM gene
The BLM gene is located on the long (q) arm of
chromosome 15 at position 2
It is known as the "caretaker of the genome.“
It maintains the structure and integrity of DNA.
42. Function of BLM gene
The BLM gene provides instructions for making a
member of a protein family called helicases.
Helicases are enzymes that bind to DNA and
temporarily unwind the two spiral strands (double
helix) of the DNA molecule.
43. Mutations in BLM gene
Mutated BLM gene
Mutated BLM protein
Frequency of sister chromatids exchange increased
Causes chromosome instability with gaps and breaks in
Genetic material
Uncontrolled cell growth
CANCER
44. Failure to thrive in infancy
Hyperpigmentation of skin
Facial telangectasias
Increased risk of malignancies
Immunodeficiency
Growth retardation
Clinical features
45. DIAGNOSIS
CYTOGENETIC ANALYSIS:Quadriradial
configuration .The 4-armed figure consists of 2
homologous chromosomes caused by chromosome
breaks and rearrangements.
Another cytogenetic abnormality observed in
Bloom syndrome is a sharply increased SCE level
IMMUNOGLOBULINS:Decreased
49. XERODERMA PIGMENTOSUM
It is caused by an abnormality in an individual’s
genome.
Mutations in the XP genes (except XP-variant) lead
to defective NER and hypersensitivity to UV
It can also be caused by environmental factors.
Eight genes are involved in XP: XPA through XPG
and XPV (XP-Variant)
Autosomal recessive disorder.